Citations of scientific results and conflicts of interest: The case of mammography screening

Evidence-Based Medicine

Volumn 18, Issue 3, 2013, Pages 83-89

  Rasmussen, Kristine ^a   Jørgensen, Karsten Juhl ^a   Gøtzsche, Peter C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCREENING; CONFLICT OF INTEREST; DATA EXTRACTION; GERIATRIC NURSING; HUMAN; MAMMOGRAPHY; MEDICAL LITERATURE; NATIONAL HEALTH ORGANIZATION; PRACTICE GUIDELINE; SYSTEMATIC REVIEW (TOPIC);

PUBLIC HEALTH; QUALITATIVE RESEARCH;

BIBLIOMETRICS; BREAST NEOPLASMS; CONFLICT OF INTEREST; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MEDICINE; PERIODICALS AS TOPIC;

EID: 84878190326     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/eb-2012-101216     Document Type: Article

References (33)

1. Olsen O, Gøtzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2001;CD001877.
2. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2. (Pubitemid 33016501)
3. Gøtzsche PC. Mammography screening: truth, lies and controversy. London: Radcliffe Publishing, 2012.
4. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006;CD001877.
5. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009;CD001877.
6. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302:1685-92.
7. Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010;340:c1241.
8. Autier P, Boniol M, Gavin A, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:d4411.
9. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
10. Morrell S, Barratt A, Irwing L, et al. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2010;21:275-82.
11. Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012;156:491-9.
12. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37.
13. Canadian Task Force on Preventive Health CareTonelli M, Gorber SC, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011;183:1991-2001.
14. Autier P, Boniol M, Middleton R, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 2011;22:1726-35.
15. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008;168:2311-16.
16. Zahl PH, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol 2011;12:1118-24.
17. Añorbe E, Aisa P. Screening mammography. Radiology 2003;227:903-4.
18. Edwards QT, Li AX, Pike MC, et al. Ethnic differences in the use of regular mammography: the multiethnic cohort. Breast Cancer Res Treat 2009;115:163-70.
19. Jørgensen KJ, Klahn A, Gøtzsche PC. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med 2007;5:12.
20. Norris SL, Burda BU, Holmer HK, et al. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol 2012;65:725-33.
21. International Committee of Medical Journal Editors, 2012. http://www.icmje.org/journals.html#I (accessed 24 Apr 2013).
22. Riva C, Biollaz J, Foucras P, et al. Effect of population-based screening on breast cancer mortality. Lancet 2012;379:1296.
23. World Association of Medical Editors, 2013. http://www.wame.org/about (accessed 24 Apr 2013).
24. Richards M. An independent review is under way. BMJ 2011;343:d6843.
25. Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA 2010;303:164-5.
26. Nelson HD, Naik A, Humphrey L, et al. The background review for the USPSTF recommendation on screening for breast cancer. Ann Intern Med 2010;152:538-9.
27. Dickersin K, Tovey D, Wilcken N, et al. The background review for the USPSTF recommendation on screening for breast cancer. Ann Intern Med 2010;152:537.
28. Sherman ME, Howatt W, Blows FM, et al. Molecular pathology in epidemiologic studies: a primer on key considerations. Cancer Epidemiol Biomarkers Prev 2010;19:966-72.
29. The Annals of Internal Medicine Editors. When evidence collides with anecdote, politics, and emotion: breast cancer screening. Ann Intern Med 2010;152:531-2.
30. McCartney M. Selling health to the public. BMJ 2010;341:c6639.
31. Lyratzopoulos G, Barbiere JM, Rachet B, et al. Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol 2011;22:1661-6.
32. Stein R. Federal panel recommends reducing number of mammograms. The Washington Post 17 November, 2009.
33. Horton R. Screening mammography-an overview revisited. Lancet 2001;358:1284-5.